Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
35.30
0.00 (0.00%)
Jun 6, 2025, 10:52 AM CET
-24.25%
Market Cap 164.62M
Revenue (ttm) 350.00K
Net Income (ttm) -18.71M
Shares Out 4.66M
EPS (ttm) -4.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4
Average Volume 338
Open 35.30
Previous Close 35.30
Day's Range 35.30 - 35.30
52-Week Range 33.00 - 56.80
Beta 0.98
RSI 48.99
Earnings Date May 22, 2025

About Poltreg

Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 33
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.

Financial Statements

News

There is no news available yet.